Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor‐specific antibodies von Croze, Laure‐Emmanuelle, Tetaz, Rachel, Roustit, Matthieu, Malvezzi, Paolo, Janbon, Bénédicte, Jouve, Thomas, Pinel, Nicole, Masson, Dominique, Quesada, Jean‐Louis, Bayle, François, Zaoui, Philippe

Volltext